These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8101300)

  • 1. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A
    Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
    Veeger NJ; Zijlstra F; Hillege HL; van der Meer J;
    Ann Thorac Surg; 2010 Nov; 90(5):1515-21. PubMed ID: 20971252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
    Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Dunselman PH; Mulder BJ; Michels HR; Buser PT; van Gilst WH; Lie KI
    Thromb Haemost; 1994 Nov; 72(5):676-81. PubMed ID: 7900073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Thromb Res Suppl; 1990; 12():11-21. PubMed ID: 2082483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial.
    Lancet; 2000 Jan; 355(9201):346-51. PubMed ID: 10665553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
    Sanz G
    Thromb Res Suppl; 1990; 12():23-6. PubMed ID: 2082484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion.
    Weber MA; Hasford J; Taillens C; Zitzmann A; Hahalis G; Seggewiss H; Langbehn AF; Fassbender D; Buchwalsky R; Theisen K
    Am J Cardiol; 1990 Dec; 66(20):1464-8. PubMed ID: 2251993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
    Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. CABADAS. Research Group of the Interuniversity Cardiology Institute of The Netherlands. Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/phenoprocoumon Study.
    Tan ES; van der Meer J; Jan de Kam P; Dunselman PH; Mulder BJ; Ascoop CA; Pfisterer M; Lie KI
    J Am Coll Cardiol; 1999 Nov; 34(6):1760-8. PubMed ID: 10577567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
    Guiteras P; Altimiras J; Arís A; Augé JM; Bassons T; Bonal J; Caralps JM; Castellarnau C; Crexells C; Masotti M
    Eur Heart J; 1989 Feb; 10(2):159-67. PubMed ID: 2647494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G; Heiman F; Lavezzari M; Marubini E
    Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
    Yli-Mäyry S; Huikuri HV; Korhonen UR; Airaksinen KE; Ikäheimo MJ; Linnaluoto MK; Takkunen JT
    Eur Heart J; 1992 Sep; 13(9):1259-64. PubMed ID: 1396838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.